Skip to main content
Device Global Header

Subscribe
or Renew

Advanced Search

This article is available to subscribers. Subscribe now. Already have an account? Sign in

EditorialFree Preview

Planned Parenthood at Risk

List of authors.
  • George P. Topulos, M.D.,
  • Michael F. Greene, M.D.,
  • and Jeffrey M. Drazen, M.D.

Planned Parenthood is under attack — again. This time, a campaign of misinformation about the retrieval of fetal tissue used in research and therapy is the excuse. When women have made the decision to terminate a pregnancy, Planned Parenthood allows them the opportunity to have the fetal tissue that would otherwise be discarded be used by qualified researchers to help answer important medical questions. The organization does so carefully, following all applicable laws and ethical guidelines. In a Perspective article now published in the Journal, Charo presents compelling arguments defending these uses of fetal tissue.1 Planned Parenthood, its physicians, and . . .

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Funding and Disclosures

Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.

Dr. Topulos reports serving as a volunteer member of the medical committees of both Planned Parenthood League of Massachusetts and Planned Parenthood Federation of America.

This article was published on August 12, 2015, at NEJM.org.

Author Affiliations

From the Department of Anaesthesia, Harvard Medical School, and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital (G.P.T.); and the Department of Obstetrics and Gynecology, Massachusetts General Hospital (M.F.G.) — all in Boston.

Print Subscriber? Activate your online access.